about
Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.Activation of the gab operon in an RpoS-dependent manner by mutations that truncate the inner core of lipopolysaccharide in Escherichia coliPrevalence and antimicrobial susceptibility patterns of bacteria from milkmen and cows with clinical mastitis in and around Kampala, UgandaRates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infectionEffectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort studyDirect nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in UgandaAnti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national surveyAetiology of pulmonary symptoms in HIV-infected smear negative recurrent PTB suspects in Kampala, Uganda: a cross-sectional studyElucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencingOptimizing tuberculosis case detection through a novel diagnostic device placement model: the case of UgandaAntimicrobial susceptibility profiles of Escherichia coli and Klebsiella pneumoniae isolated from outpatients in urban and rural districts of UgandaPredominance of Uganda genotype of Mycobacterium tuberculosis isolated from Ugandan patients with tuberculous lymphadenitisPerformance of three LED-based fluorescence microscopy systems for detection of tuberculosis in UgandaFeasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter StudyDrug resistance-related mutations in multidrug-resistant Mycobacterium tuberculosis isolates from diverse geographical regions.Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score.Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in UgandaHigh prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda.Evaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, UgandaMycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in peri-urban Kampala, UgandaDNA restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from HIV-seropositive and HIV-seronegative patients in Kampala, Uganda.Sensitivity of direct versus concentrated sputum smear microscopy in HIV-infected patients suspected of having pulmonary tuberculosisDirect susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda.Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda.Use of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural UgandaIn vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.Rhomboid homologs in mycobacteria: insights from phylogeny and genomic analysis.Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda.The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.How we determined the most reliable solid medium for studying treatment of tuberculosis.Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individualsSecondary attack rate of tuberculosis in urban households in Kampala, Uganda.Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in UgandaMycobacterium tuberculosis spoligotypes and drug susceptibility pattern of isolates from tuberculosis patients in South-Western Uganda.Clinical and epidemiological characteristics of individuals resistant to M. tuberculosis infection in a longitudinal TB household contact study in Kampala, Uganda.Feasibility of magnetic bead technology for concentration of mycobacteria in sputum prior to fluorescence microscopyProspective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosisRate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, UgandaCampylobacter spp among children with acute diarrhea attending Mulago hospital in Kampala--Uganda.
P50
Q22242234-CDA82B40-A1DA-4426-A202-9460D487C196Q24559928-83FDA8D4-2C5D-4B95-8CE6-6083A1749DB7Q27320803-FE62E882-128C-4A9B-9643-F53F20EB6AEEQ28476713-EA8FAEC2-29CA-4F73-8631-91666377B51CQ28477435-574A71B8-AD01-42F5-AA18-C2615FC62C3FQ28478104-471CDF14-65EC-4557-A856-2A917EE7C00DQ28535035-B6141898-550B-4C7A-98E3-9F403EFF568AQ28535816-73F86B41-86FB-49E9-92DE-3572B630EE71Q28536869-E79C6BCE-4531-4931-96CC-18929D4A89D9Q28545265-31537112-403C-46EC-ABBA-8D0EBAC29EFDQ28603838-E82EF7FC-EE81-421F-9D13-09CD48CA536DQ28608182-3BCD0A9D-06F6-43E6-84BD-FAA84AF0BDF0Q28743934-5E53F1D3-EF67-4B06-8682-CDB9D740246CQ28828650-FBC65F42-4068-41A2-9B34-A7AA72C829EDQ30224460-E765DA29-36CF-4587-8D7E-EB7B95F7ED6DQ30417688-618496D8-376B-4D45-BA29-CF5AB11BEBCFQ30541989-D912FA8A-79A5-4A14-BB0F-635BC5D5FA7AQ31030501-911E0616-9A2C-4805-9086-DADADF7FEF59Q31088965-10D642FC-E288-4B84-AA31-69E690ED4F75Q33355670-2F8AFE17-2DA4-4DF4-B185-2E35DA9547A3Q33406007-8660A288-7283-4B63-9DBA-1DEA0CEA453DQ33439988-C5DA6E7F-25F2-4A84-88CF-92DB58079263Q33449024-5B6A586C-078C-45BA-89D9-A84B70020DFFQ33497027-EDB1FA19-440C-499A-863E-F72CF0E067D4Q33534845-42D908E5-A2C3-4616-ACE3-2DB6BE24ADE7Q33651616-F3169550-1AD1-41E2-B9D3-84E0C5FD3C85Q33676088-DE42FE61-5CF9-4DA4-99C2-35B7FBDC9C43Q33732240-6A65059C-85C6-4888-8F25-578E82DC73ECQ33767099-A72846E8-A7F8-4807-9AC6-62F0360BFE79Q33798212-0B94A713-B658-4C5B-8916-E27B5F11E769Q33805377-A365F1B7-6B9E-4484-89EE-8EF585DF27C8Q33820488-EB6F5D83-A247-4E1E-A591-7C22D6673BB7Q33826137-55ADDB21-3488-4A51-864D-F678C9CE0944Q33855961-177E9CBF-62F2-47C6-9BCC-9DFD18F731EAQ33858850-E94C126C-D184-4993-93B5-1F29378DE8E4Q33880649-6CE91189-7649-45DB-A4EA-156D1594B7BDQ33899020-9CDCEB5F-1B93-467A-A553-D52C98866700Q33899999-0EB56F97-582F-4E19-8EF0-7E109AD6782BQ33904830-71CBE8BB-C11C-409B-BA28-777D0DF2AE34Q33918672-0CB0958B-29A8-4680-8E4C-DE775A80CB64
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Moses Joloba
@ast
Moses Joloba
@en
Moses Joloba
@es
Moses Joloba
@nl
Moses Joloba
@sl
type
label
Moses Joloba
@ast
Moses Joloba
@en
Moses Joloba
@es
Moses Joloba
@nl
Moses Joloba
@sl
prefLabel
Moses Joloba
@ast
Moses Joloba
@en
Moses Joloba
@es
Moses Joloba
@nl
Moses Joloba
@sl
P108
P106
P21
P31
P496
0000-0002-0334-9983
P569
2000-01-01T00:00:00Z